Cytosolic Delivery of Doxorubicin from Liposomes to Multidrug-Resistant Cancer Cells via Vaporization of Perfluorocarbon Droplets

A common mechanism of multidrug resistance is the upregulation of efflux pumps in the cancer cells that can more rapidly export unwanted materials (e.g. cancer drugs) out of the cell, compared to sensitive cancer cells. This research seeks to overcome this mechanism by vaporizing a perfluoropentane...

Full description

Saved in:
Bibliographic Details
Main Author: Williams, Jacob B (author)
Other Authors: Buchanan, Clara M. (author), Husseini, Ghaleb (author), Pitt, William G. (author)
Format: article
Published: 2017
Subjects:
Online Access:http://hdl.handle.net/11073/21316
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513442038153216
author Williams, Jacob B
author2 Buchanan, Clara M.
Husseini, Ghaleb
Pitt, William G.
author2_role author
author
author
author_facet Williams, Jacob B
Buchanan, Clara M.
Husseini, Ghaleb
Pitt, William G.
author_role author
dc.creator.none.fl_str_mv Williams, Jacob B
Buchanan, Clara M.
Husseini, Ghaleb
Pitt, William G.
dc.date.none.fl_str_mv 2017
2021-02-02T09:56:12Z
2021-02-02T09:56:12Z
dc.format.none.fl_str_mv application/pdf
dc.identifier.none.fl_str_mv Williams JB, Buchanan CM, Husseini G, Pitt WG (2017) Cytosolic Delivery of Doxorubicin from Liposomes to Multidrug-Resistant Cancer Cells via Vaporization of Perfluorocarbon Droplets. J Nanomed Res 5(4): 00122. DOI: 10.15406/jnmr.2017.05.00122
2377-4282
http://hdl.handle.net/11073/21316
10.15406/jnmr.2017.05.00122
dc.language.none.fl_str_mv en_US
dc.publisher.none.fl_str_mv MedCrave
dc.relation.none.fl_str_mv https://doi.org/10.15406/jnmr.2017.05.00122
dc.subject.none.fl_str_mv Controlled drug delivery
Doxorubicin
KB cancer cells
Perfluorocarbon droplet vaporization
Liposome
Multidrug resistance
dc.title.none.fl_str_mv Cytosolic Delivery of Doxorubicin from Liposomes to Multidrug-Resistant Cancer Cells via Vaporization of Perfluorocarbon Droplets
dc.type.none.fl_str_mv Peer-Reviewed
Published version
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
description A common mechanism of multidrug resistance is the upregulation of efflux pumps in the cancer cells that can more rapidly export unwanted materials (e.g. cancer drugs) out of the cell, compared to sensitive cancer cells. This research seeks to overcome this mechanism by vaporizing a perfluoropentane emulsion droplet inside of a drug-containing liposome (eLiposome) that was endocytosed into a cancer cell. Folate attached to the eLiposome facilitates uptake into the cell as observed by confocal microscopy. Ultrasound was examined as a trigger to initiate the vaporization of the perfluoropentane droplet and release doxorubicin from folated eLiposomes (feLD). Two seconds of ultrasound released 78% of encapsulated doxorubicin from feLD. Doxorubicin-sensitive KB-3-1 cells and doxorubicin-resistant KB-V1 cells treated with feLD (without ultrasound) had cell viabilities of 33% and 60%, respectively. Ultrasound had negligible additional effect on the cell viability of KB-3-1 and KB-V1 cells treated with feLD (33% and 53%, respectively). We hypothesized that the doxorubicin sulfate fibers that were formed during the loading of doxorubicin into the eLiposome present a site for heterogeneous nucleation once the feLD is endocytosed by the cell, and thus droplet vaporization occurs with or without ultrasound.
format article
id aus_53417e61163eba6cc5f1ec72f3254df9
identifier_str_mv Williams JB, Buchanan CM, Husseini G, Pitt WG (2017) Cytosolic Delivery of Doxorubicin from Liposomes to Multidrug-Resistant Cancer Cells via Vaporization of Perfluorocarbon Droplets. J Nanomed Res 5(4): 00122. DOI: 10.15406/jnmr.2017.05.00122
2377-4282
10.15406/jnmr.2017.05.00122
language_invalid_str_mv en_US
network_acronym_str aus
network_name_str aus
oai_identifier_str oai:repository.aus.edu:11073/21316
publishDate 2017
publisher.none.fl_str_mv MedCrave
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Cytosolic Delivery of Doxorubicin from Liposomes to Multidrug-Resistant Cancer Cells via Vaporization of Perfluorocarbon DropletsWilliams, Jacob BBuchanan, Clara M.Husseini, GhalebPitt, William G.Controlled drug deliveryDoxorubicinKB cancer cellsPerfluorocarbon droplet vaporizationLiposomeMultidrug resistanceA common mechanism of multidrug resistance is the upregulation of efflux pumps in the cancer cells that can more rapidly export unwanted materials (e.g. cancer drugs) out of the cell, compared to sensitive cancer cells. This research seeks to overcome this mechanism by vaporizing a perfluoropentane emulsion droplet inside of a drug-containing liposome (eLiposome) that was endocytosed into a cancer cell. Folate attached to the eLiposome facilitates uptake into the cell as observed by confocal microscopy. Ultrasound was examined as a trigger to initiate the vaporization of the perfluoropentane droplet and release doxorubicin from folated eLiposomes (feLD). Two seconds of ultrasound released 78% of encapsulated doxorubicin from feLD. Doxorubicin-sensitive KB-3-1 cells and doxorubicin-resistant KB-V1 cells treated with feLD (without ultrasound) had cell viabilities of 33% and 60%, respectively. Ultrasound had negligible additional effect on the cell viability of KB-3-1 and KB-V1 cells treated with feLD (33% and 53%, respectively). We hypothesized that the doxorubicin sulfate fibers that were formed during the loading of doxorubicin into the eLiposome present a site for heterogeneous nucleation once the feLD is endocytosed by the cell, and thus droplet vaporization occurs with or without ultrasound.MedCrave2021-02-02T09:56:12Z2021-02-02T09:56:12Z2017Peer-ReviewedPublished versioninfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfWilliams JB, Buchanan CM, Husseini G, Pitt WG (2017) Cytosolic Delivery of Doxorubicin from Liposomes to Multidrug-Resistant Cancer Cells via Vaporization of Perfluorocarbon Droplets. J Nanomed Res 5(4): 00122. DOI: 10.15406/jnmr.2017.05.001222377-4282http://hdl.handle.net/11073/2131610.15406/jnmr.2017.05.00122en_UShttps://doi.org/10.15406/jnmr.2017.05.00122oai:repository.aus.edu:11073/213162024-08-22T12:05:14Z
spellingShingle Cytosolic Delivery of Doxorubicin from Liposomes to Multidrug-Resistant Cancer Cells via Vaporization of Perfluorocarbon Droplets
Williams, Jacob B
Controlled drug delivery
Doxorubicin
KB cancer cells
Perfluorocarbon droplet vaporization
Liposome
Multidrug resistance
status_str publishedVersion
title Cytosolic Delivery of Doxorubicin from Liposomes to Multidrug-Resistant Cancer Cells via Vaporization of Perfluorocarbon Droplets
title_full Cytosolic Delivery of Doxorubicin from Liposomes to Multidrug-Resistant Cancer Cells via Vaporization of Perfluorocarbon Droplets
title_fullStr Cytosolic Delivery of Doxorubicin from Liposomes to Multidrug-Resistant Cancer Cells via Vaporization of Perfluorocarbon Droplets
title_full_unstemmed Cytosolic Delivery of Doxorubicin from Liposomes to Multidrug-Resistant Cancer Cells via Vaporization of Perfluorocarbon Droplets
title_short Cytosolic Delivery of Doxorubicin from Liposomes to Multidrug-Resistant Cancer Cells via Vaporization of Perfluorocarbon Droplets
title_sort Cytosolic Delivery of Doxorubicin from Liposomes to Multidrug-Resistant Cancer Cells via Vaporization of Perfluorocarbon Droplets
topic Controlled drug delivery
Doxorubicin
KB cancer cells
Perfluorocarbon droplet vaporization
Liposome
Multidrug resistance
url http://hdl.handle.net/11073/21316